Prof. Chierchia & Dr. Della Rocca share their perspectives on the PERFECT-PAF trial, which evaluates the clinical safety and economic value of FARAPULSE^TM PFA compared to cryoablation (CBA). In the interview, they highlight the study's design and key findings, along with its impact on clinical practice.